Innoviva Appoints Stephen Basso As Chief Financial Officer >INVA
Innoviva 2Q EPS 2c >INVA
FDA approves Innoviva's bacterial pneumonia treatment
Innoviva 1Q EPS 42c >INVA
Innoviva Announces Retirement Of Board Chairman >INVA
Innoviva Shares Rise 7% After Pneumonia Drug's Approval by FDA Committee
Innoviva Shares Halted as FDA Panel Reviews Sulbactam-Durlobactam >INVA
Theravance Stock Drops on Covid-19 Therapy Disappointment
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.